Companies · Other Health Care

Ecph, Llc

DALLAS · Other Health Care

Diligence memoA one-page analyst read on Ecph, Llc — recommendation, valuation, rhythm, risks.
$285.4M
Total raised · real
9
Rounds
2.7×
Latest step-up
Top 2%
Sector rank · raised
Series D+
Latest stage · inferred · Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Ecph, Llc looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.79× the median modeled value of Series D+ Other Health Care companies in 2022–2024 (17 peers) — value vs value, same stage and era.
  • Within the normal band (79% of peer median) for its niche.
Dormant
  • Last raise 4.1 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Ecph, Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
9.3 yr record
Peak capital year was 2022 with $119.9M across 4 filings.
Market position
ahead of 99% of Other Health Care peers
Capital scale is ahead of 99% of Other Health Care peers; modeled value is above 96% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2022: $119.9M across 4 filings.
  • Largest single filing was $115.3M on 2021-05-06.
  • Filing rows sum to $353.8M, while canonical raised total is $285.4M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Ecph, Llc is one of 5376 Other Health Care companies tracked from DALLAS. By capital raised it ranks among the largest (ahead of 99% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
190
Investors (latest)
2017
Year incorporated
2022-05-16
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$1.3B$2.5B$3.8B$5.0BSeries B · 2017-03-27 Raised $29M (real) Modeled valuation $649M (est)Series B2017Series C · 2018-12-21 Raised $58M (real) Modeled valuation $1.3B (est)Series C2018Series C · 2019-03-08 Raised $1.5M (real) Modeled valuation $34M (est)Series C2019Series C · 2019-06-21 Raised $180K (real) Modeled valuation $4.1M (est)Series C2019Series A · 2020-02-26 Raised $6.0M (real) Modeled valuation $121M (est)Series A2020Series C · 2020-02-26 Raised $9.5M (real) Modeled valuation $218M (est)Series C2020Seed · 2020-02-26 Raised $1.1M (real) Modeled valuation $27M (est)Seed2020Series C · 2020-06-26 Raised $13M (real) Modeled valuation $286M (est)Series C2020Series D+ · 2021-05-06 Raised $115M (real) Modeled valuation $2.2B (est)Series D+2021Series D+ · 2021-08-13 Raised $250K (real) Modeled valuation $4.6M (est)Series D+2021Series B · 2022-05-16 Raised $39M (real) Modeled valuation $493M (est)Series B2022Pre-Seed · 2022-05-16 Raised $405K (real) Modeled valuation $4.9M (est)Pre-Seed2022Series B · 2022-05-16 Raised $22M (real) Modeled valuation $269M (est)Series B2022Series D+ · 2022-05-16 Raised $59M (real) Modeled valuation $915M (est)Series D+2022Cumulative $354M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$29.3M · 2017
Series C$58.3M · 2018
Series C extension$1.5M · 2019
Series C extension$180K · 2019
Bridge · Series C-stage$6.0M · 2020smaller follow-on
Series C extension$9.5M · 2020
Bridge · Series C-stage$1.1M · 2020smaller follow-on
Series C extension$12.5M · 2020
Series D+$115.3M · 2021
Series D+ extension$250K · 2021
Bridge · Series D+-stage$39.4M · 2022smaller follow-on
Bridge · Series D+-stage$405K · 2022smaller follow-on
Bridge · Series D+-stage$21.5M · 2022smaller follow-on
Series D+ extension$58.6M · 2022

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$914.9M
Base estimate est.
$312.0M
Conservative case
$1.6B
Upside case
$488.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series D+a $100M–$400M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series B · modeled $649.3M · 2017-03-272017Series C · modeled $1.3B · 2018-12-21Series C · modeled $33.6M · 2019-03-08Series C · modeled $4.1M · 2019-06-21Series A · modeled $121.1M · 2020-02-26Series C · modeled $217.9M · 2020-02-26Seed · modeled $26.9M · 2020-02-26Series C · modeled $285.8M · 2020-06-26Series D+ · modeled $2.2B · 2021-05-06Series D+ · modeled $4.6M · 2021-08-13Series B · modeled $492.9M · 2022-05-16Pre-Seed · modeled $4.9M · 2022-05-16Series B · modeled $269.2M · 2022-05-16Series D+ · modeled $914.9M · 2022-05-162022
Model inputs · modeled:benchmark-stage-stepup-v1
12%
Dilution assumption
Implied ownership sold in the financing.
80%
Survival probability
64% low · 88% high
1.23×/yr
Annual markup
1.38×/yr upside case
4.1 yr
Elapsed time used
4.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
5 mo
Avg between rounds
$55.6M/yr
Capital velocity
9.3 yr
On record since
2017
First round
14
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 117× above median
This company$285.4M
Sector median$2.4M
Latest round — vs other Series D+ rounds in sector (real $, this stage) 0.5× of median
This company$58.6M
Sector median$123.0M
Modeled value — vs sector median (estimate, all stages) 41× above median
This company$914.9M
Sector median$22.1M

Raised more than 99% of sector peers (real $). Modeled value above 96% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series D+) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #11 of 17.

This companyCohort peer
$100.0M$1.0B$10.0B$100.0M$1.0BCapital raised (log)United Digestive Holdings, LLC · Series D+ Raised $323.3M · modeled $4.2B (est)DispatchHealth Holdings, Inc. · Series D+ Raised $578.0M · modeled $3.7B (est)Zimmer Biomet Holdings, Inc. · Series D+ Raised $216.1M · modeled $2.9B (est)Main Street Rural, Inc. · Series D+ Raised $211.2M · modeled $2.4B (est)Richmond Buyer L.P. · Series D+ Raised $232.6M · modeled $2.2B (est)Thirty Madison, Inc. · Series D+ Raised $255.7M · modeled $1.8B (est)Ember Management Aggregator, L.P. · Series D+ Raised $129.9M · modeled $1.8B (est)Glooko, Inc. · Series D+ Raised $221.0M · modeled $1.2B (est)Renovaro Inc. · Series D+ Raised $123.3M · modeled $1.2B (est)HistoSonics, Inc. · Series D+ Raised $308.2M · modeled $1.0B (est)Cortica Inc. · Series D+ Raised $210.9M · modeled $757.4M (est)Ecph, Llc (this company) Raised $285.4M · modeled $914.9M (est)Ecph, Llc
CompanyStageRaised · realValue · estvs peer med.
United Digestive Holdings, LLCSeries D+$323.3M$4.2B3.63×
DispatchHealth Holdings, Inc.Series D+$578.0M$3.7B3.17×
Zimmer Biomet Holdings, Inc.Series D+$216.1M$2.9B2.50×
Main Street Rural, Inc.Series D+$211.2M$2.4B2.07×
Richmond Buyer L.P.Series D+$232.6M$2.2B1.93×
Thirty Madison, Inc.Series D+$255.7M$1.8B1.56×
Ember Management Aggregator, L.P.Series D+$129.9M$1.8B1.55×
Glooko, Inc.Series D+$221.0M$1.2B1.05×
Renovaro Inc.Series D+$123.3M$1.2B1.00×
HistoSonics, Inc.Series D+$308.2M$1.0B0.87×
Ecph, Llc this companySeries D+$285.4M$914.9M0.79×
Cortica Inc.Series D+$210.9M$757.4M0.65×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$29.3M2017-03-27$162.8M$649.3M90%
Series C$58.3M2018-12-21$388.8M$1.3B90%
Series C$1.5M2019-03-08$9.8M$33.6M90%
Series C$180K2019-06-21$1.2M$4.1M90%
Series A$6.0M2020-02-26$27.3M$121.1M90%
Series C$9.5M2020-02-26$63.6M$217.9M90%
Seed$1.1M2020-02-26$5.4M$26.9M90%
Series C$12.5M2020-06-26$83.3M$285.8M90%
Series D+$115.3M2021-05-06$960.6M$2.2B90%
Series D+$250K2021-08-13$2.1M$4.6M90%
Series B$39.4M2022-05-16$219.0M$492.9M90%
Pre-Seed$405K2022-05-16$2.2M$4.9M90%
Series B$21.5M2022-05-16$119.6M$269.2M90%
Series D+$58.6M2022-05-16$488.0M$914.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$29.3M2017-03-27
    • First recorded raise — entered as Series B.
    • 14 investors on this round.
  2. Series C$58.3M2018-12-21
    • Raised again after 21 mo — slower than the ~14 mo sector norm.
    • Round 2.0× larger than the prior — scaling up.
    • 25 investors on this round.
  3. Series C$1.5M2019-03-08
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 39.7× smaller than the prior — bridge or down round.
    • 17 investors on this round.
  4. Series C$180K2019-06-21
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 8.2× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  5. Series A$6.0M2020-02-26
    • Raised 8 mo later, in step with the ~14 mo sector norm.
    • Round 33.3× larger than the prior — scaling up.
    • 1 investor on this round.
  6. Series C$9.5M2020-02-26
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.6× larger than the prior — scaling up.
    • 31 investors on this round.
  7. Seed$1.1M2020-02-26
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 8.8× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  8. Series C$12.5M2020-06-26
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 11.5× larger than the prior — scaling up.
    • 21 investors on this round.
  9. Series D+$115.3M2021-05-06
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 9.2× larger than the prior — scaling up.
    • 5 investors on this round.
  10. Series D+$250K2021-08-13
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 461.1× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  11. Series B$39.4M2022-05-16
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round 157.7× larger than the prior — scaling up.
    • 127 investors on this round.
  12. Pre-Seed$405K2022-05-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 97.3× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  13. Series B$21.5M2022-05-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 53.2× larger than the prior — scaling up.
    • 66 investors on this round.
  14. Series D+$58.6M2022-05-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.7× larger than the prior — scaling up.
    • 190 investors on this round.
Intelligence
2022 ~Q4
Modeled next raise · ~5mo cadence
$159.3M
Modeled next size est.range $103.6M$254.9M
2.7×
Last step-up
$55.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Jeff S. Fronterhouse7 other2017-03
F. Barron Fletcher III4 other2018-12
F. Barron S. Fletcher III2 other2017-03
Charles W. Matthews1 other2017-03
David Barron Carrig1 other2020-02
Douglas C. Shepard1 other2017-03
Eric Barron Anderson1 other2020-02
Eric S. Anderson1 other2018-12
George Barron Gebhardt1 other2018-12
George C. Gebhardt1 other2017-03
Glenn Barron Askew III1 other2018-12
Glenn W. Askew III1 other2017-03
James S. Bradford1 other2018-12
Jeff Barron Browning1 other2018-12
Jeff W. Browning1 other2017-03
Jim C. Denny1 other2017-03
John Barron Carlyle1 other2020-02
John Barron Pitts1 other2020-02
John S. Carlyle1 other2018-12
Warren C. Meyer1 other2017-03
Warren S. Meyer1 other2018-12
C. Brett Barron Burford2022-05
James Barron Bradford2020-02
Jay Barron Bradford2020-06
Registry & provenance

Ecph, Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1702434
SEC CIK
2017
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Acuity EyeCare Rollover II, LLCOther Health CareSeries A$9.8M$61.2Mnetwork13 shared operators · same sector
Acuity EyeCare Rollover, LLCOther Health CareSeries A$5.7M$115.0Mnetwork9 shared operators · same sector
VSH CorpOther Health CareSeries D+$108.2M$2.5Bnetwork1 shared operator · same sector · same stage
Riata Acuity, LPOther Health CareSeries A$7.1M$142.3Mnetwork2 shared operators · same sector
Repligen CorpOther Health CareSeries D+$290.6M$1.1Bsame sector · same stage
Preventice Solutions, Inc.Other Health CareSeries D+$275.3M$1.0Bsame sector · same stage
Aeneas Parent Corp.Other Health CareSeries D+$298.3M$644.1Msame sector · same stage
HistoSonics, Inc.Other Health CareSeries D+$308.2M$1.0Bsame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
ECP Manco, LLCOther Health CareSeries C$78.3M85%
Aetas Co LLCOther Health CarePre-Seed$30.8M85%
North Texas Renal Management, LLCOther Health CareSeed$6.6M84%
EO Enterprises, LLCOther Health CarePre-Seed$623K84%
Mediportal LlcOther Health CareSeries A$114.3M83%
Mbf/Chh, LlcOther Health CareSeries A$123.1M83%
EQH Parent, LLCOther Health CareSeries D+$6.7B83%
Empericus, LLCOther Health CarePre-Seed$23.1M83%
Frequently asked
How much funding has Ecph, Llc raised?
Ecph, Llc has raised approximately $285.4M in disclosed capital across 9 recorded financing rounds, aggregated from public filings.
What is Ecph, Llc's estimated valuation?
Provath's modeled valuation for Ecph, Llc is approximately $914.9M (modeled range $312.0M–$1.6B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Ecph, Llc at?
Ecph, Llc's latest modeled financing stage is Series D+. Its most recent recorded round closed around Mon May 16.
What does Ecph, Llc do and where is it based?
Ecph, Llc operates in the Other Health Care sector, based in DALLAS.
Explore related

See where Ecph, Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Ecph, Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.